PHOENIX, AZ—Middle meningeal artery (MMA) embolization with liquid agents looks set to become the standard of care for the treatment of nonacute subdural hematoma after three randomized trials ...
PHOENIX -- For chronic or subacute subdural hematoma, embolization of the middle meningeal artery (MMA) reduced recurrence, three randomized trials showed. Two trials with the Onyx liquid embolic ...
A novel combination of surgery and embolization used to treat subdural hematomas, bleeding between the brain and its protective membrane due to trauma, reduces the risk of follow-up surgeries, ...
The treatment of a subdural hematoma received a major boost with three new randomized controlled trials all showing large and significant benefits of a new embolization process done as an endovascular ...
A novel combination of surgery and embolization used to treat subdural hematomas, bleeding between the brain and its protective membrane due to trauma, reduces the risk of follow-up surgeries, ...
A novel combination of surgery and embolization used to treat subdural hematomas, bleeding between the brain and its protective membrane due to trauma, reduces the risk of follow-up surgeries, ...
BOSTON, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Balt, Inc., a global technology leader in neurovascular devices, today announced the publication of The Squid Trial for the Embolization of the Middle ...
A randomized, controlled study of a novel liquid embolic, NeoCast, adjunctive to surgery WALTHAM, Mass., May 21, 2026--(BUSINESS WIRE)--Arsenal Medical, a clinical-stage company developing innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results